OTC Drug Spending By Some Insurers Hindered By Antitrust Law
This article was originally published in The Tan Sheet
Executive Summary
Statutory caps on nonprescription drug spending by not-for-profit insurers could pose a significant barrier to expanded use of over-the-counter products